Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -133.29% is 16% below its 5-year average of -115.18%, around the middle of its 5-year range (-224.55%–-34.68%).
As of the fiscal period ended Tuesday, June 30, 2026. 9.42% above its 12-month average of -147.16%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q1 FY2027 (2026-06-30): -133.29%.
RETURN ON INVESTED CAPITAL (ROIC)
-133.29%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-147.16%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-151.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-115.18%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-113.10%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+9.42%
CURRENT VS 3Y AVG
+11.73%
CURRENT VS 5Y AVG
-15.72%
CURRENT VS 10Y AVG
-17.85%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.77%
median of 763 covered companies
CURRENT VS SECTOR MEDIAN
-283.36%
vs the sector median at left
Aethlon Medical, Inc.
Market Cap
$3.29M
Return on Invested Capital (ROIC)
-133.29%
TTM Avg
-147.16%
3Y Avg
-151.01%
5Y Avg
-115.18%
Market Cap
$3.29M
Return on Invested Capital (ROIC)
-284.81%
TTM Avg
-319.42%
3Y Avg
-246.02%
5Y Avg
-246.02%
Market Cap
$3.23M
Return on Invested Capital (ROIC)
-9.72%
TTM Avg
-8.51%
3Y Avg
-19.00%
5Y Avg
-22.23%
Market Cap
$3.23M
Return on Invested Capital (ROIC)
-75.31%
TTM Avg
-107.77%
3Y Avg
-224.28%
5Y Avg
-195.58%
Market Cap
$3.21M
Return on Invested Capital (ROIC)
-69.04%
TTM Avg
-69.04%
3Y Avg
-66.04%
5Y Avg
-57.92%
Market Cap
$3.13M
Return on Invested Capital (ROIC)
-184.27%
TTM Avg
-194.39%
3Y Avg
-144.44%
5Y Avg
-112.27%
Market Cap
$3.12M
Return on Invested Capital (ROIC)
-104.28%
TTM Avg
-131.89%
3Y Avg
-356.58%
5Y Avg
-286.34%
Market Cap
$3.53M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.49M
Return on Invested Capital (ROIC)
-45.77%
TTM Avg
-25.13%
3Y Avg
-754.36%
5Y Avg
-475.60%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aethlon Medical, Inc. (AEMD) | $3.29M | -133.29% | -147.16% | -151.01% | -115.18% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.29M | -284.81% | -319.42% | -246.02% | -246.02% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.23M | -9.72% | -8.51% | -19.00% | -22.23% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.23M | -75.31% | -107.77% | -224.28% | -195.58% |
| MBody AI Ltd. (MBAI)vs › | $3.21M | -69.04% | -69.04% | -66.04% | -57.92% |
| IceCure Medical Ltd (ICCM)vs › | $3.13M | -184.27% | -194.39% | -144.44% | -112.27% |
| Revelation Biosciences, Inc. (REVB)vs › | $3.12M | -104.28% | -131.89% | -356.58% | -286.34% |
| Eocene Ltd. (EOCN)vs › | $3.53M | N/A | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | -45.77% | -25.13% | -754.36% | -475.60% |
| Nexalin Technology, Inc. (NXL)vs › | $3.51M | -600.62% | -217.41% | -160.53% | -160.53% |
ROIC
-133.3%
ROE
-133.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -133.29% |
| 2026-03-31 | -149.27% |
| 2025-12-31 | -108.36% |
| 2025-09-30 | -120.32% |
| 2025-06-30 | -224.55% |
| 2025-03-31 | -171.09% |
| 2024-12-31 | -206.74% |
| 2024-09-30 | -177.66% |
| 2024-06-30 | -127.60% |
| 2024-03-31 | -196.95% |
| 2023-12-31 | -151.49% |
| 2023-09-30 | -107.14% |
| 2023-06-30 | -88.71% |
| 2023-03-31 | -74.35% |
| 2022-12-31 | -72.21% |
| 2022-09-30 | -61.52% |
| 2022-06-30 | -72.50% |
| 2022-03-31 | -59.23% |
| 2021-12-31 | -42.69% |
| 2021-09-30 | -38.50% |
| 2021-06-30 | -34.68% |
| 2021-03-31 | -84.90% |
| 2020-12-31 | -64.82% |
| 2020-09-30 | -43.07% |
| 2020-06-30 | -37.98% |
| 2020-03-31 | -63.63% |
| 2019-12-31 | -148.14% |
| 2019-09-30 | -6023.90% |
| 2019-06-30 | -318.94% |
| 2019-03-31 | -183.94% |
| 2018-12-31 | -138.44% |
| 2018-09-30 | -99.29% |
| 2018-06-30 | -79.70% |
| 2018-03-31 | -70.28% |
| 2017-12-31 | -93.53% |
| 2017-09-30 | -641.93% |
| 2017-06-30 | -6075.15% |
| 2017-03-31 | -547.15% |
| 2016-12-31 | -1367.22% |
| 2016-09-30 | -1170.33% |
| 2016-06-30 | -446.14% |
| 2016-03-31 | -215.95% |
| 2015-12-31 | -140.95% |
| 2015-09-30 | -105.12% |
| 2015-06-30 | -73.44% |
| 2015-03-31 | -495.03% |
| 2014-12-31 | -232.08% |
